Comprehensive Clinical Solutions L L C is categorized under Medical Labs in Mokena, IL and active since 2010.
Comprehensive Clinical Solutions L L C was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Michael G Ernest at the company’s single location by writing to 19533 Regent Drive, Mokena, Illinois IL 60448 or by phoning (708) 220-5158. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Comprehensive Clinical Solutions L L C |
| Contact Person: | Michael G Ernest |
| Address: | 19533 Regent Drive, Mokena, Illinois 60448 |
| Phone Number: | (708) 220-5158 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
Comprehensive Clinical Solutions L L C was started in 2010 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Michael G Ernest for inquiries that concern Comprehensive Clinical Solutions L L C by calling the company number (708) 220-5158, as your correspondence is most welcome. Additionally, the physical location of the single location of Comprehensive Clinical Solutions L L C can be found at the coordinates 41.534034,-87.867355 as well as the street address 19533 Regent Drive in Mokena, Illinois 60448.
For its online presence, you may visit Comprehensive Clinical Solutions L L C’s website at and engage with its social media outlets through on Twitter and on Facebook.